Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis
- 1 November 1988
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 235 (8) , 449-453
- https://doi.org/10.1007/bf00314245
Abstract
Azathioprine (Aza) has been used alone or in combination with steroids for two groups of myasthenic patients. Positive responses were noted in 75% of patients on Aza alone and in 70% receiving the combined regimen. The clinical course of the two groups differed in terms of respiratory crisis and need for plasma exchange. With an appropriate Aza administration schedule side-effects were not a limiting factor to its use. Aza treatment induced a reduction in anti-AchR-antibody level that was correlated with clinical improvement and greatly decreased the need for steroids.This publication has 23 references indexed in Scilit:
- The Course of Myasthenia Gravis in Patients Treated with Corticosteroids, Azathioprine, and PlasmapheresisaAnnals of the New York Academy of Sciences, 1987
- Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia GravisNew England Journal of Medicine, 1987
- Rapid improvement of myasthenia gravis after plasma exchangeAnnals of Neurology, 1982
- PLASMA EXCHANGE ALONE AS THERAPY FOR MY ASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1981
- EFFELCT OF PLASMAPHERESIS IN MYASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1981
- RESPONSE TO PLASMAPHERESIS AND IMMUNOSUPPRESSIVE DRUG THERAPY IN SIXTY MY ASTHENIA GRAVIS PATIENTSAnnals of the New York Academy of Sciences, 1981
- Controversies about the treatment of myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- EFFECTS OF SOME IMMUNOSUPPRESSIVE PROCEDURES ON MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1976
- IMMUNOSUPPRESSIVE DRUGS IN TREATMENT OF MYASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1971
- The Treatment of Severe Myasthenia Gravis with Immunosuppressive AgentsEuropean Neurology, 1969